MCT4 as a Potential Therapeutic Target to Augment Gemcitabine Chemosensitivity in Resected Pancreatic Cancer

By
Justin.choi
-
0
10
Investigators identified the prognostic significance and therapeutic options of metabolic subtypes of resectable pancreatic cancer.
[Cellular Oncology]

Sorry, but the selected Zotpress account can't be found.

Abstract